What is ADXN's revenue growth forecast for 2024-2024?
(NASDAQ: ADXN) Addex Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Addex Therapeutics's revenue in 2024 is $1,830,076.
In 2024, ADXN is forecast to generate $395,617,442 in revenue, with the lowest revenue forecast at $395,617,442 and the highest revenue forecast at $395,617,442.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.